In these individuals, who were randomised to placebo or treatment with pravastatin, IL-6, CRP, and fibrinogen all predicted cardiovascular death, and IL-6 in particular added significantly to conventional risk factors in predicting those suffering fatal myocardial infarction or fatal stroke. Here, IL6 is linked to Stroke.